Kura Oncology (KURA) executive compensation, 2026 proxy

Troy E. Wilson, Ph.D., J.D., President and Chief Executive Officer, was paid $4.7M in fiscal 2025, down 24% from $6.2M the year before.

Filed
April 10, 2026
Annual meeting
June 4, 2026
Pay year
fiscal 2025
Named executives
3
CEO total pay
$4.7M-24% vs prior year
CEO Target Bonus
60%Percentage of annual base salary
CEO 2025 Salary
$700,000Effective January 1, 2025

How J.D. was paid

$4.7M in total for fiscal 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary15%Option awards70%Non-equity incentive13%All other compensation2%

Named executive officers

ExecutiveTotal
Troy E. Wilson, Ph.D., J.D.President and Chief Executive Officer$4,735,016
Brian PowlChief Commercial Officer$2,669,238
Kathleen FordChief Operating Officer$1,902,487

What changed and why

  • $6.2MCEO total compensation decreased from $6,242,348 in 2024 to $4,735,016 in 2025.
  • $672KCEO base salary increased from $671,736 to $700,000 for fiscal 2025.
  • $4.9MOption awards for the CEO decreased from $4,942,840 to $3,297,250 in 2025.
  • $630KNon-equity incentive plan compensation for the CEO increased to $630,000 in 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.